Clinical trials
Recruiting Phase 1 Biliary Tract Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Henry Ford Health System | 1 |
| I-Mab Biopharma US Limited | 1 |
| Kestrel Therapeutics, Inc. | 1 |
| Myeloid Therapeutics | 1 |
| NextCure, Inc. | 1 |
| SEED Therapeutics, Inc. | 1 |
| SK Life Science, Inc. | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Shenzhen Xinhe Biomedical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 19 |
| Colorectal Neoplasms | 8 |
| Stomach Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Cholangiocarcinoma | 5 |
| Endometrial Neoplasms | 5 |
| Esophageal Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Hepatocellular | 3 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.